Kimball Electronics, Inc. (KE) - 10-K Summary
Business Context and Reporting Period
Company: Kimball Electronics, Inc.
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal Year ended June 30, 2025
Business Overview: A global provider of electronics manufacturing services (EMS) and contract manufacturing organization (CMO) solutions. The company serves automotive, medical, and industrial end markets, offering durable electronics, high-level assemblies, and medical disposables. Operations are aggregated into one reportable segment with facilities in the U.S., China, Mexico, Poland, Romania, and Thailand.
Key Financial Metrics (Fiscal Year 2025)
| Metric | 2025 (in millions) | 2024 (in millions) | % Change |
|---|---|---|---|
| Net Sales | $1,486.7 | $1,714.5 | (13)% |
| Gross Profit | $104.4 | $140.3 | (26)% |
| Gross Margin | 7.0% | 8.2% | -120 bps |
| Operating Income | $45.5 | $49.3 | (8)% |
| Net Income | $17.0 | $20.5 | (17)% |
| Diluted EPS | $0.68 | $0.81 | (16)% |
| Operating Cash Flow | $183.9 | $73.2 | 151% |
| Debt (Total Borrowings) | $147.5 | $294.8 | (50)% |
| Cash & Equivalents | $88.8 | $78.0 | 14% |
| Current Ratio | 2.2 | 2.3 | - |
| Debt-to-Equity | 0.3 | 0.5 | - |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 13% due to a loss of a major automotive program, end-of-life automotive programs, customer overstocking in the medical sector, and the divestiture of the GES business unit (completed July 2024).
- Margin Compression: Gross margin declined to 7.0% from 8.2% primarily due to lost absorption on lower revenue volumes.
- Restructuring & Divestiture: The company recorded $11.0 million in restructuring expenses (up from $2.4 million) related to workforce resizing and the closure of the Tampa facility. A $2.4 million gain was recognized on the disposal of GES assets.
- Debt Reduction: Total borrowings decreased significantly to $147.5 million from $294.8 million, driven by net payments on credit facilities of $147.3 million.
- Working Capital Efficiency: Operating cash flow surged to $183.9 million, driven by a $71.8 million reduction in receivables and a $74.6 million reduction in inventory levels.
Guidance, Outlook, and Risks
- Outlook: Management expects consolidated net sales in fiscal 2026 to decline marginally from 2025 levels, largely due to the continued impact of the lost major automotive program. Moderate growth is expected in the medical sector.
- Strategic Actions: The company is closing its Tampa facility (assets held for sale) and expanding its medical CMO footprint with a new leased facility in Indiana. Capital expenditure commitments are approximately $35 million.
- Key Risks:
- Customer Concentration: Nexteer Automotive (19% of sales) and ZF (11% of sales) represent significant revenue concentration.
- Supply Chain: Ongoing risks of component shortages, particularly semiconductors, and potential tariff impacts on international trade.
- Geopolitical: Exposure to international operations in China, Poland, Romania, and Thailand creates vulnerability to currency fluctuations and geopolitical instability.
- Program Lifecycle: The business model relies on replacing expiring programs with new ones; new program start-ups often cause early margin dilution.
Investor Verification Checklist
- Automotive Exposure: Verify the specific timeline and revenue impact of the "major automotive program" loss and the status of replacement programs.
- GES Divestiture: Confirm the final proceeds from the GES sale and the classification of remaining assets held for sale (Tampa facility).
- Inventory Levels: Assess the sustainability of the inventory reduction trend and the risk of obsolescence given the lower sales volume.
- Customer Concentration: Monitor the stability of relationships with Nexteer Automotive and ZF, which collectively account for 30% of net sales.
- Restructuring Costs: Track the execution of the Tampa closure and associated costs, estimated at $5.5 million to $6.5 million total.